PHARMACAR: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACAR
Largest movements
- Receivables after one year +€188,800
up €188,800, from €0 to €188,800
of which Other amounts receivable: +€188,800
- Current investments +€96,082
up €96,082 (+32.0%), from €300,000 to €396,082
- Stocks and contracts +€63,832
up €63,832 (+8.6%), from €739,894 to €803,726
- Financial fixed assets +€59,014
up €59,014, from €0 to €59,014
- Receivables within one year -€38,899
down €38,899 (-7.2%), from €540,470 to €501,571
of which Trade receivables: -€86,194
- Trade debts +€400,755
up €400,755 (+569%), from €70,387 to €471,143
- Tax, wage and social debts -€55,755
down €55,755 (-73.5%), from €75,818 to €20,063
- Gross operating margin -€278,618
down €278,618 (-35.3%), from €789,492 to €510,874
- Taxes -€86,466
down €86,466 (-37.3%), from €232,002 to €145,536
- Other operating charges +€9,702
up €9,702 (+151%), from €6,417 to €16,120
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,243,687 | €2,564,850 | +€321,163 | +14.3% |
| Fixed assets | 21/28 | €87,430 | €113,292 | +€25,862 | +29.6% |
| Intangible fixed assets | 21 | €23,739 | €16,773 | -€6,967 | -29.3% |
| Tangible fixed assets | 22/27 | €63,691 | €37,505 | -€26,185 | -41.1% |
| Plant, machinery and equipment | 23 | €1,770 | €2,817 | +€1,047 | +59.2% |
| Furniture and vehicles | 24 | €8,233 | €3,191 | -€5,041 | -61.2% |
| Leasing and similar rights | 25 | €45,007 | €31,203 | -€13,804 | -30.7% |
| Other tangible fixed assets | 26 | €8,681 | €293 | -€8,387 | -96.6% |
| Financial fixed assets | 28 | €0 | €59,014 | +€59,014 | |
| Current assets | 29/58 | €2,156,257 | €2,451,558 | +€295,302 | +13.7% |
| Amounts receivable after more than one year | 29 | €0 | €188,800 | +€188,800 | |
| Trade receivables | 290 | €0 | - | = | |
| Other amounts receivable | 291 | - | €188,800 | +€188,800 | |
| Stocks and contracts in progress | 3 | €739,894 | €803,726 | +€63,832 | +8.6% |
| Stocks | 30/36 | €739,894 | €803,726 | +€63,832 | +8.6% |
| Amounts receivable within one year | 40/41 | €540,470 | €501,571 | -€38,899 | -7.2% |
| Trade receivables | 40 | €539,506 | €453,312 | -€86,194 | -16.0% |
| Other amounts receivable | 41 | €963 | €48,259 | +€47,296 | +4,910% |
| Current investments | 50/53 | €300,000 | €396,082 | +€96,082 | +32.0% |
| Cash at bank and in hand | 54/58 | €566,249 | €551,704 | -€14,545 | -2.6% |
| Deferred charges and accrued income | 490/1 | €9,644 | €9,675 | +€31 | +0.3% |
| Total equity and liabilities | 10/49 | €2,243,687 | €2,564,850 | +€321,163 | +14.3% |
| Equity | 10/15 | €2,049,495 | €2,036,613 | -€12,882 | -0.6% |
| Contributions | 10/11 | €98,600 | €98,600 | = | 0.0% |
| Reserves | 13 | €1,694,640 | €1,683,424 | -€11,216 | -0.7% |
| Distributable reserves | 133 | €1,694,640 | €1,683,424 | -€11,216 | -0.7% |
| Profit (loss) carried forward | 14 | €256,255 | €254,589 | -€1,666 | -0.7% |
| Amounts payable | 17/49 | €194,192 | €528,237 | +€334,045 | +172% |
| Amounts payable after more than one year | 17 | €27,756 | €12,943 | -€14,812 | -53.4% |
| Financial debts | 170/4 | €27,756 | €12,943 | -€14,812 | -53.4% |
| Amounts payable within one year | 42/48 | €165,468 | €514,295 | +€348,827 | +211% |
| Current portion of amounts payable after more than one year | 42 | €15,718 | €14,812 | -€906 | -5.8% |
| Financial debts | 43 | €291 | €356 | +€65 | +22.4% |
| Credit institutions | 430/8 | €291 | €356 | +€65 | +22.4% |
| Trade debts | 44 | €70,387 | €471,143 | +€400,755 | +569% |
| Suppliers | 440/4 | €70,387 | €471,143 | +€400,755 | +569% |
| Taxes, remuneration and social security | 45 | €75,818 | €20,063 | -€55,755 | -73.5% |
| Taxes | 450/3 | €75,818 | €20,063 | -€55,755 | -73.5% |
| Other amounts payable | 47/48 | €3,255 | €7,921 | +€4,667 | +143% |
| Accrued charges and deferred income | 492/3 | €968 | €998 | +€31 | +3.2% |
| Non-recurring operating income | 76A | €12,850 | €0 | -€12,850 | -100% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €30,337 | €28,021 | -€2,316 | -7.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €1,384 | €0 | -€1,384 | -100% |
| Other operating charges | 640/8 | €6,417 | €16,120 | +€9,702 | +151% |
| Non-recurring operating charges | 66A | €6,072 | €2,119 | -€3,953 | -65.1% |
| Gross operating margin | 9900 | €789,492 | €510,874 | -€278,618 | -35.3% |
| Operating profit (loss) | 9901 | €745,282 | €464,615 | -€280,668 | -37.7% |
| Financial income | 75/76B | €5,219 | €3,485 | -€1,734 | -33.2% |
| Recurring financial income | 75 | €5,219 | €3,485 | -€1,734 | -33.2% |
| Financial charges | 65/66B | €11,880 | €11,384 | -€496 | -4.2% |
| Recurring financial charges | 65 | €11,880 | €11,384 | -€496 | -4.2% |
| Profit (loss) for the period before taxes | 9903 | €738,621 | €456,716 | -€281,905 | -38.2% |
| Income taxes | 67/77 | €232,002 | €145,536 | -€86,466 | -37.3% |
| Profit (loss) for the period | 9904 | €506,619 | €311,180 | -€195,439 | -38.6% |
| Profit (loss) for the period to be appropriated | 9905 | €506,619 | €311,180 | -€195,439 | -38.6% |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.